AUTHORS
Thomas J. Girard, PhD, Irem Eldem, MD2, Lilian Antunes Heck, PhD3, Nina Lasky4, George Broze Jr, MD5, Jorge Di Paola, MD6
AFFILIATIONS
1 Washington University School of Medicine, St. Louis, Missouri, United States
2 Washington University School of Medicine, St. Louis, Missouri, United States
3 Washington University School of Medicine, St. Louis, Missouri, United States
4 Washington University School of Medicine, St. Louis, Missouri, United States
5 Deceased 7/19/2019, St. Louis, Missouri, United States
6 Washington University School of Medicine, St. Louis, Missouri, United States
ABSTRACT
Background. TFPI regulates coagulation by inhibiting FXa and the FVIIa/TF complex. Humans and mice express three-Kunitz-domain TFPIα, and membrane-anchored two-Kunitz-domain TFPIβ. Some of this TFPI is proteolytically processed into the predominant circulating lipoprotein-associated two-Kunitz-domain TFPI. Unlike humans, mice also express TFPIγ, which generates a similar lipoprotein-associated two-Kunitz-domain TFPI isoform. A key difference between human and mouse TFPI is that mice have approximately 20-fold higher circulating levels of the 2-Kunitz-domain TFPI isoform than humans. The Kunitz-2 (K2) domain of TFPI interacts with and inhibits FXa, whereas, in a FXa-dependent manner, the Kunitz-1 (K1) domain inhibits the FVIIa/TF complex. TFPI Kunitz-1 (exon 4) deletion (TFPIΔK1) causes embryonic lethality establishing TFPI’s essential role in restraining the FVIIa/TF complex. However, which of the remaining specific TFPI activities (direct FXa inhibition, protein-S cofactor activity and prothrombinase inhibition) are required for development remain unresolved.
Approach. To define the essential functions of TFPI during development, we compared TFPI-null mice, with TFPIΔK1 mice, which express TFPI isoforms deficient in FVIIa/TF inhibition while retaining (albeit decreased) the other TFPI activities.
Results. As expected, targeted deletion of the TFPI signal peptide and K1 (exons 3 and 4) eliminated all TFPI protein expression (TFPI-null) and caused embryonic lethality. Genotyped at weaning, transgenic human TFPIα and TFPIβ each rescued both TFPIΔK1 mice and TFPI-null mice. Expression of XK1A, a selective direct inhibitor of FVIIa, fully rescued TFPIΔK1 mice but failed to rescue any TFPI-null mice. Similarly, PAR4 deficiency, previously reported to rescue approximately 40% of TFPIΔK1 mice, rescued 31% of TFPIΔK1 mice in our study but did not rescue TFPI-null mice. Timed matings confirmed our previous findings, with 63% survival of TFPIΔK1 embryos at embryonic day (E)11.5; in contrast, no viable TFPI-null embryos were identified at E11.5 (0/94 embryos). Treatment of pregnant dams with the FXa inhibitor rivaroxaban restored survival of 38% of TFPI-null embryos at E11.5 (p=0.003). Compared with wild-type littermates, E10.5 TFPI-null embryos were smaller, pale, lacked vascular red coloration, and appeared developmentally arrested. Analysis of embryonic expression databases demonstrated conserved expression patterns of F3 (TF), FVII, FX, TFPI, and PROS/Pros (protein S) between humans and mice, including similar yolk sac-, placenta-, liver-, and overall developmental expression profiles.
Discussion. The embryonic lethality of TFPIΔK1 mice demonstrates that TFPI-mediated inhibition of FVIIa/TF is essential for development. However, because TFPI requires FXa binding to inhibit FVIIa/TF, loss of the FXa inhibitory domain eliminates both direct FXa inhibition and FXa-dependent FVIIa/TF inhibition, preventing assessment of their individual roles in development. To overcome this limitation, we generated a XK1A transgene that mimics the FXa-TFPI complex and directly inhibits FVIIa/TF, independently of FXa. The rescue of the TFPIΔK1 mice by XK1A confirms the potency of this approach. The inability of XK1A to rescue TFPI-null mice demonstrates that direct FXa inhibition by TFPI is essential for embryonic development. In XK1A-rescued TFPIΔK1 mice, this critical FXa inhibitory activity is provided by the remaining TFPIΔK1 isoforms, establishing that both FVIIa/TF and FXa inhibition contribute independently to TFPI-mediated developmental protection.
Summary. Collectively, our rescue studies demonstrate 1) complete TFPI deficiency causes a more severe phenotype than TFPI Kunitz-1 deletion; 2) TFPI’s direct FXa inhibition and FVIIa/TF inhibition are both necessary and sufficient for embryonic development; 3) either human TFPIα or TFPIβ can rescue TFPI-null mice, thus, neither TFPIα’s protein S cofactor activity, TFPIα-mediated prothrombinase inhibition, nor the glycosyl-phosphatidyl-inositol (GPI) membrane anchor to TFPIβ are required for developmental rescue. Together, these studies establish that TFPI’s critical developmental role is mediated by its core anticoagulant functions, FXa and FVIIa/TF inhibition, while excluding previously proposed nonessential isoform-specific activities.
DISCLOSURES
Thomas J. Girard, PhD: No relevant conflicts of interest to declare.